Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xerafy is a private Singapore-based RFID and industrial IoT company that designs rugged RFID tags, labels, sensors, and related asset-tracking solutions for industrial and healthcare environments. The company is not a drug developer; instead, it serves hospitals, medical device manufacturers, and pharmaceutical companies with sterilization-ready and autoclavable RFID products for surgical instrument tracking, sterile processing, pharmacy inventory, medical supplies, and other traceability workflows. Xerafy also operates across manufacturing, aerospace, oil and gas, logistics, and MRO, positioning its technology as part of a broader "Connected Assets" digital transformation platform. Its business is commercial-stage and product-driven, with revenue generated from hardware, engineering, and implementation support through partners rather than from a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xerafy.